TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: sleep resumption time after nurse‐assisted patient turning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Catch up growth of testicular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial respiration during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of protein kinase Akt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shock anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: device acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Formation of the terminal SC5b‐9 complement complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Counts of circulating leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Counts of circulating platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: reintubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: LpA‐I concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: apoA‐II concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Infarct size (IS) at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transmurality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of chronic rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: duration of vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammation control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: percent days using substances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of tumor ADC measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients in NYHA class I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with no symptoms of angina pectoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of activity patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of psychological predictors (SELF and INTENT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time until starting liquid diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until starting solid diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 8-year recurrence-free survival (RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Grasping-errors during dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Positive symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disorganized thoughts score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncontrolled hostility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin resistance level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of HCV
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of HIV
Endpoint domain: Mortality/survival
Primary endpoint: Needle sharing behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-PSS Quality of Life (IPSS QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average number of nocturnal micturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Block performance pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital survival rate
Endpoint domain: Mortality/survival
Primary endpoint: delta FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PC20 (histamine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: shoulder active range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: upper extremity isometric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of chorioamnionitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: risk of neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of lifetime prescription drug misuse
Endpoint domain: Adverse events/effects
Primary endpoint: Healing process
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of complete removal of carcinoid tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intragastric pH maintained above 4.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients with intragastric pH > 4.0 for more than 12 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bilateral parietotemporal hypoperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attitudes and intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maternal-neonatal morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: reduction in hazardous and harmful drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention completion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: selfish behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: last-night net use among adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: last-night net use among children under five
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimation of daily steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total METs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light METs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of AGA II IgA and IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force during sustained maximal voluntary muscle contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS activation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Engagement in Advance Care Planning (ACP)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: End-of-Life (EOL) discussion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Durable Power of Attorney (DPOA)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: NRS shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in serum HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional performance on the first postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at third assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hSBA geometric mean titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportion of subjects with postvaccination hSBA titers 1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportion of seroresponders for serogroups A, W‐135, and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response rates at Day 21 and Day 84
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission/euthymia rates at Day 21 and Day 84
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of haptic perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of fracture healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of orientation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent recall of autobiographical information
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep duration at nighttime
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Activity level at nighttime
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Decrease in HIV-DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ACR Pediatric 30 responses
Endpoint domain: Physiological/clinical
Primary endpoint: Child Health Questionnaire physical and psychosocial summary scores
Endpoint domain: Life impact
Primary endpoint: Improvement in depression, anxiety and stress scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increases in secretion rates of salivary immunoglobulin‐A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decreases in salivary cortisol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: linear bone fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cardiovascular death or HF hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of incomplete blockade necessitating reinjection
Endpoint domain: Adverse events/effects
Primary endpoint: Interruption of oncologic therapy related to mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Need for nasogastric tube nutrition
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of trismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-minute step test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment cost per cured patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area under the plasma concentration-time curve (AUC 0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness ratio per AECB-symptom day averted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cost-utility ratio per QALY gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum 25(OH)D response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔE* values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Identification of subsequent psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Resistance to fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Lipid oxidation during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease of hemoglobin after catheter placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: BMD changes at the femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor impersistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASER latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous blink rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of gastric erosions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: distress reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worry reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: discharge prescription rates of targeted secondary prevention medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebreathing incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety symptom reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating GLP-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circulating GIP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circulating insulin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement of shoulder function score (Constant Murley Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in Prevotella intermedia species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Killing of Fusobacterium nucleatum and Treponema denticola species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Tannerella forsythensis count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Markers of inflammation in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: targeted histological yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: tumour size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P300-N100 amplitude differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional outcome assessed by the Dallas Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global patients' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: infant feeding concerns
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postpartum pain concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accessing government programs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in PBVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of active lesions evolving into persistent black holes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed progression on the EDSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VDI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal delivery within 24 hours of initiation of induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Average interval from start of induction to vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of doses required for induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction of pre-operative complaints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dietary intake of vegetables and sugar-sweetened beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage reduction in all types of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: imagery scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean C(max,IAsp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0‐120 min,IAsp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0‐120 min,GIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corrected visual acuity worse than 20/400
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corrected visual acuity worse than 20/60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scars in the visual axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentile weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque index score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Candidal counts reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HVA concentration in sera
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ACT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in motor and comprehensive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of risks associated with baby walkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative attitudes towards baby walkers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Likelihood to discuss baby walkers in the antenatal period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: teachers' behavioural assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self reported ability to concentrate
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in seizure frequency (SFs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: observational pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of required visits to a physician
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average cost per person
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BMI (Body Mass Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall success rate of tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: GA-1 yields of PMNs per U
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: GA-2 yields of PMNs per U
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: days off from school or work
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Controlled hypertension (BP <140/90 mm Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Loss of response during follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infusion reactions leading to cessation of biosimilar
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MED (Minimal Erythema Dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Uptake of cervical screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: surgical cure rate
Endpoint domain: Mortality/survival
Primary endpoint: Complete catheter occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased Claudication Distance (ICD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased Resting Ankle-Brachial Index (r-ABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased Post-Exercise Ankle-Brachial Index (p-eABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postprandial change in flow-mediated vasodilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HFNS problem rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in whole-body BMD (ΔWB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in femoral neck BMD (ΔFN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversal of anti-FXa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous thromboembolism recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Stability of Blood Pressure (BP) and Heart Rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes